One Facial Photo, and You're Told '90 Days to Live'... A Modern-Day Grim Reaper?
"It Could Be Useful When Medical Information Is Limited"
An artificial intelligence (AI) tool that predicts the survival chances of cancer patients from a single facial photo has been developed. It is expected to be particularly useful when medical information is limited.
Calculates Patient-Specific Risk Scores... Also Estimates Age
AI Model Predicts Cancer Patient Survival and Estimates Biological Age. Mass General Brigham Website
View original imageBloomberg reported on October 19 (local time), citing a paper published in the medical journal The Lancet Digital Health. The AI tool was trained to estimate a person's age and predict the survival prospects of cancer patients. It was trained on more than 40 million facial images and photos of more than 30,000 cancer patients, including people who had died.
One notable feature is its ability to calculate a risk score for each patient. Patients with higher scores were found to face a greater risk of dying within 90 days.
Raymond Mak, the paper's co-corresponding author and a professor at Harvard Medical School (a radiation oncologist at Mass General Brigham Cancer Institute), said, "Doctors are trained to assess a patient's health by observing their appearance, but they are generally not very good at estimating how long a patient nearing the end of life has left to live." He explained, "I think AI can help assess a person's physiological reserve and risk of death to some extent from just a single facial photo."
Some Urge Caution About Clinical Use
The use of AI in cancer detection, diagnosis, and treatment has been growing in recent years. Its applications are also expanding, from analyzing medical imaging results to help with diagnosis to predicting cancer risk based on genetic factors and lifestyle habits.
Miroslav Bober, a professor of image processing and machine learning at the University of Surrey in the UK, who was not involved in the study, viewed the findings positively but cautioned against applying them in clinical settings without care.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
"Predicting an outcome is different from explaining it," Professor Bober said, noting that "it has not been demonstrated that the tool provides clinically useful information beyond a doctor's assessment of a patient's overall health and fitness." He added that the tool would need to undergo comparative validation against doctors' own judgment, as well as validation involving other hospitals and patient groups.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.